DE60300862D1 - Verbesserungen an oder in bezug auf arzneizusammensetzungen - Google Patents

Verbesserungen an oder in bezug auf arzneizusammensetzungen

Info

Publication number
DE60300862D1
DE60300862D1 DE60300862T DE60300862T DE60300862D1 DE 60300862 D1 DE60300862 D1 DE 60300862D1 DE 60300862 T DE60300862 T DE 60300862T DE 60300862 T DE60300862 T DE 60300862T DE 60300862 D1 DE60300862 D1 DE 60300862D1
Authority
DE
Germany
Prior art keywords
pharmaceutical compositions
alginate
polyol
bicarbonate
poly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60300862T
Other languages
English (en)
Other versions
DE60300862T2 (de
Inventor
Eugenie Axford
Andrew Dickson
Gordon Jolliffe
Rolf Myrvold
Paul Marshall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Reckitt Benckiser Healthcare UK Ltd
Original Assignee
Reckitt Benckiser Healthcare UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt Benckiser Healthcare UK Ltd filed Critical Reckitt Benckiser Healthcare UK Ltd
Publication of DE60300862D1 publication Critical patent/DE60300862D1/de
Application granted granted Critical
Publication of DE60300862T2 publication Critical patent/DE60300862T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/734Alginic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Lubricants (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dental Preparations (AREA)
DE60300862T 2002-02-12 2003-02-07 Verbesserungen an oder in bezug auf arzneizusammensetzungen Expired - Lifetime DE60300862T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0203269A GB2384986B (en) 2002-02-12 2002-02-12 Compositions for the treatment of disorders of the upper gastrointestinal tract
GB0203269 2002-02-12
PCT/GB2003/000593 WO2003068246A2 (en) 2002-02-12 2003-02-07 Improvements in or relating to compositions

Publications (2)

Publication Number Publication Date
DE60300862D1 true DE60300862D1 (de) 2005-07-21
DE60300862T2 DE60300862T2 (de) 2006-05-11

Family

ID=9930901

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60300862T Expired - Lifetime DE60300862T2 (de) 2002-02-12 2003-02-07 Verbesserungen an oder in bezug auf arzneizusammensetzungen

Country Status (17)

Country Link
US (1) US20050069583A1 (de)
EP (1) EP1474154B1 (de)
JP (1) JP4276545B2 (de)
KR (1) KR100976071B1 (de)
CN (1) CN1315483C (de)
AT (1) ATE297742T1 (de)
AU (1) AU2003205868B2 (de)
CA (1) CA2474520C (de)
DE (1) DE60300862T2 (de)
ES (1) ES2242939T3 (de)
GB (1) GB2384986B (de)
MX (1) MXPA04007779A (de)
PL (1) PL210931B1 (de)
PT (1) PT1474154E (de)
RU (1) RU2317087C2 (de)
WO (1) WO2003068246A2 (de)
ZA (1) ZA200405848B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005018613A1 (de) * 2003-08-26 2005-03-03 Mandapro Ag Pellets für die orale applikation von pharmazeutischen wirkstoffen
JP2006342085A (ja) * 2005-06-08 2006-12-21 Kao Corp Gip分泌抑制剤
GB0515492D0 (en) * 2005-07-28 2005-08-31 Reckitt Benckiser Healthcare Improvements in or relating to compositions,articles and methods
SE530184C2 (sv) * 2005-12-23 2008-03-18 Kjell Stenberg Bioadhesiv farmaceutisk filmkomposition innehållande lågviskösa alginater
EP1859786A1 (de) * 2006-05-16 2007-11-28 Frutarom Netherlands B.V. Methode zu vermindern die Symptome von Sodbrennen und Gastro-speiseröhren Rücklaufkrankheit durch spezifischen polysaccharides
KR100919508B1 (ko) * 2007-08-14 2009-09-28 강원대학교산학협력단 매트릭스에 칼슘 카보네이트를 함유한 알지네이트 입자 및그 제조방법
GB0814376D0 (en) * 2008-08-06 2008-09-10 Reckitt Benckiser Healthcare Formulation
WO2010092468A1 (en) * 2009-02-13 2010-08-19 Carlo Ghisalberti Composition comprising alginates and d-limonene to treat gerd and dyspepsia
WO2010108494A1 (en) * 2009-03-25 2010-09-30 S-Biotek Holding Aps Dayspepsia treatment with alginate
JP5909851B2 (ja) * 2010-02-24 2016-04-27 大正製薬株式会社 易嚥下性錠剤
BR112012026860A2 (pt) * 2010-04-23 2018-06-05 S Biotek Holding Aps composição farmacêutica sólida para neutralizar ácido estomacal
KR101307293B1 (ko) * 2011-05-24 2013-09-26 주식회사 인트로팜텍 알긴산 화합물을 포함하는 과립형 약학 조성물, 및 이의 제조방법
EA025430B1 (ru) * 2012-01-27 2016-12-30 Государственное Научное Учреждение "Институт Биоорганической Химии Национальной Академии Наук Беларуси" Фармацевтическая композиция в качестве субстанции антирефлюксного антацидного препарата
WO2019016356A1 (en) 2017-07-20 2019-01-24 Solvay Sa FUNCTIONALIZED PARTICULATE BICARBONATE AS EXPANSION AGENT, FOAMABLE POLYMERIC COMPOSITION CONTAINING THE SAME, AND USE THEREOF IN THE PRODUCTION OF A FOAMED THERMOPLASTIC POLYMER
IT201800002625A1 (it) * 2018-02-13 2019-08-13 Drugs Minerals And Generics Italia S R L In Forma Abbreviata D M G Italia S R L Composizione in forma solida per uso nel trattamento dei sintomi extra-esofagei del reflusso gastrico
EP3758716A4 (de) * 2018-03-02 2022-03-09 Pharagen LLC Formulierungen mit natriumalginat zur behandlung von saurem reflux
CA3240038A1 (en) 2021-12-22 2023-06-29 Jose Miguel Rizo A non-swallowed, antacid chewing gum product, a process for its preparation and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1524740A (en) * 1976-11-09 1978-09-13 Reckitt & Colmann Prod Ltd Pharmaceutical compositions for use in the suppression of gastric reflux
US4613497A (en) * 1984-02-29 1986-09-23 Health Products Development, Inc. Dry, water-foamable pharmaceutical compositions
EP0159604B1 (de) * 1984-04-09 1990-11-07 Toyo Boseki Kabushiki Kaisha Präparat mit verzögerter Freigabe zum Aufbringen auf die Schleimhäute der Mundhöhle
US4818518A (en) * 1984-11-16 1989-04-04 Uop Effervescent dentifrice
US4892739A (en) * 1988-04-25 1990-01-09 Ciba-Geigy Corporation Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having a improved core membrane adhesion properties
GB9010039D0 (en) * 1990-05-03 1990-06-27 Reckitt & Colmann Prod Ltd Medicament preparation
US5817294A (en) * 1990-11-02 1998-10-06 Arnold; Michael J. Plaque adsorbent oral composition and method
US5922351A (en) * 1991-03-27 1999-07-13 Bayer Corporation Lubricants for use in tabletting
EP0725626A1 (de) * 1993-10-29 1996-08-14 RECKITT & COLMAN PRODUCTS LIMITED Schaumende gelatinkapselfullung
GB9504599D0 (en) * 1995-03-03 1995-04-26 Reckitt & Colmann Prod Ltd Improvements in or relating to organic compositions
US5908636A (en) * 1996-06-28 1999-06-01 Mcneil-Ppc, Inc. Fill material for soft gelatin pharmaceutical dosage form containing an antiflatulent
CA2288743C (en) * 1997-04-30 2008-04-22 Reckitt & Colman Products Limited Pourable alginate compositions
US6210699B1 (en) * 1999-04-01 2001-04-03 Watson Pharmaceuticals, Inc. Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity
US20020119196A1 (en) * 2000-12-21 2002-08-29 Narendra Parikh Texture masked particles containing an active ingredient

Also Published As

Publication number Publication date
GB2384986A (en) 2003-08-13
EP1474154A2 (de) 2004-11-10
JP4276545B2 (ja) 2009-06-10
CN1315483C (zh) 2007-05-16
PT1474154E (pt) 2005-10-31
AU2003205868B2 (en) 2007-05-17
KR100976071B1 (ko) 2010-08-17
US20050069583A1 (en) 2005-03-31
ATE297742T1 (de) 2005-07-15
CN1630523A (zh) 2005-06-22
DE60300862T2 (de) 2006-05-11
RU2317087C2 (ru) 2008-02-20
ES2242939T3 (es) 2005-11-16
PL210931B1 (pl) 2012-03-30
WO2003068246A3 (en) 2003-12-18
PL370141A1 (en) 2005-05-16
ZA200405848B (en) 2006-05-31
AU2003205868A1 (en) 2003-09-04
WO2003068246A2 (en) 2003-08-21
MXPA04007779A (es) 2004-10-15
RU2004127245A (ru) 2005-04-10
CA2474520A1 (en) 2003-08-21
EP1474154B1 (de) 2005-06-15
KR20040086364A (ko) 2004-10-08
JP2005517037A (ja) 2005-06-09
GB2384986B (en) 2004-01-07
GB0203269D0 (en) 2002-03-27
CA2474520C (en) 2012-04-10

Similar Documents

Publication Publication Date Title
DE60300862D1 (de) Verbesserungen an oder in bezug auf arzneizusammensetzungen
TW200500078A (en) Modified asialo-interferons and uses thereof
ATE246202T1 (de) Gcsf konjugate
ATE287705T1 (de) Wärmegellierende bioabbaubare wässrige polymerlösung
EP1196149A4 (de) IN ORGANISCHEN LÖSEMITTELN LÖSLICHE BIOLOGISCH ABBAUBARE POLY (ALKYLENOXID)- POLY (p-DIOXANON) BLOCKCOPOLYMERE SOWIE DIESE ENTHALTENDE ZUSAMMENSETZUNG ZUR ARZNEISTOFFVERABREICHUNG
BR0317822A (pt) Composição fluoroquìmica
IL163006A (en) Polyalkylene glycol polymers and conjugates thereof with biologically active compounds
ATE226240T1 (de) Xanthangummi enthaltende saure reinigungsmittel
PL1802376T3 (pl) Transparentna kompozycja kosmetyczna lub dermatologiczna
UY29647A1 (es) Estuche para alojar un envase con medicamento, así como su utilización
BR0308486A (pt) Composição tópica compreendendo um ciclofrutano, um veìculo e uma droga
UY27929A1 (es) Composiciones farmaceuticas de farmacos semiordenados y polimeros
AU2003261860A1 (en) Composition for protecting organ, tissue or cell and utilization thereof
DE60233891D1 (de) Selektives targeting von apoptotischen zellen
PL1651274T3 (pl) Żel bioadhezyjny na bazie hydroksyetylocelulozy
DK1326592T3 (da) Anvendelse af polyethylenglycol (PEG) til fremstilling af et lægemiddel til behandling af forstoppelse
NO20052680L (no) Forbedringsmiddel inneholdende brennstoff.
GB2387843A8 (en) Diol derivatives comprising hydroxy and ether groups
ATE269313T1 (de) Tryptase-inhibitoren
DK1244614T3 (da) Tryptase-inhibitorer
DK1537132T3 (da) Salt af mortin-6-glucuronid
FI20031547A0 (fi) Radiojärjestelmän miniatyyritilaajapäätelaite ja tilaajapäätelaitesetti
DOP2002000421A (es) Composiciones farmaceuticas que contienen conjunto de pollimero y farmaco.
PA8594001A1 (es) Metodo de proteccion dermica
DK1415646T3 (da) Gel omfattende et antimikrobielt ekstrakt som tilsætningsmiddel i behandlingen af periodontitis

Legal Events

Date Code Title Description
8364 No opposition during term of opposition